Yes, he is certainly selling a good story!
However you probably wouldn't shut down those markets out side orphan drugs if you wanted to add value, would think to pitch to included somehow in your pitch to add more value as you say.
We all just trying to gauge our future, but 100% I actually see partnering with Blackstone or alike as the best option they offer us what Big Parma does, cash and fire power, experience to fast track phase 3's.
Neu could give a partner % of the company for agreed sum of cash needed and we get everything we need for the cost of that % far better than giving 100% away.
Ann: 2023 Results webinar, page-117
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.200(1.47%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $3.008M | 217.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 175 | $13.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.81 | 191 | 11 |
View Market Depth
| Last trade - 15.47pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |